ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ADMA BIOLOGICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$11.07+0.39 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $2.55B
- P/E (TTM)
- 15.8
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
91.8%
206M of 224M shares
Institutional holders
323
52 new, 83 sold out
Net institutional buying
-6M
In Q2 2026
Insider trades, 12 months
5 buys · 11 sales
Net sold $1.43M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 35,907,601 | 15.10% | 13G (passive) amendment | Mar 31, 2025 |
| State Street Corporation | 17,116,022 | 7.40% | 13G (passive) | Jun 30, 2026 |
| Vanguard Capital Management | 12,110,153 | 5.08% | 13G (passive) | Mar 31, 2026 |
| Invesco Ltd. | 11,785,202 | 5.00% | 13G (passive) amendment | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ADMA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 38,355,684 | 17.12% | $321.04M | +1,524,910 | 0.00% |
| State Street Corp | 17,116,022 | 7.64% | $143.26M | +3,031,817 | 0.00% |
| Vanguard Capital Management LLC | 10,103,809 | 4.51% | $84.57M | −203,062 | 0.00% |
| Vanguard Portfolio Management LLC | 10,088,490 | 4.50% | $84.44M | +1,219,833 | 0.00% |
| Rubric Capital Management LP | 9,339,414 | 4.17% | $78.17M | +7,530,006 | 0.72% |
| Capital Research Global Investors | 8,756,374 | 3.91% | $73.29M | −2,434,742 | 0.01% |
| First Trust Advisors LP | 7,798,351 | 3.48% | $65.27M | +7,438,134 | 0.04% |
| Geode Capital Management, LLC | 6,059,984 | 2.71% | $50.73M | +235,868 | 0.00% |
| Caligan Partners LP | 5,725,007 | 2.56% | $47.92M | +968,496 | 2.25% |
| D. E. Shaw & Co., Inc. | 5,274,597 | 2.35% | $44.15M | +4,713,770 | 0.02% |
| Nantahala Capital Management, LLC | 4,719,986 | 2.11% | $39.51M | New | 0.66% |
| Dimensional Fund Advisors LP | 3,606,208 | 1.61% | $30.18M | −1,399,273 | 0.01% |
| Goldman Sachs Group Inc | 3,513,583 | 1.57% | $29.41M | +710,053 | 0.00% |
| B Group, Inc. | 3,262,542 | 1.46% | $27.31M | +55,000 | 12.82% |
| Nuveen, LLC | 3,260,349 | 1.46% | $27.29M | −2,837,876 | 0.01% |
| Duquesne Family Office LLC | 2,784,110 | 1.24% | $23.30K | +1,238,500 | 0.45% |
| Northern Trust Corp | 2,415,971 | 1.08% | $20.22M | +138,659 | 0.00% |
| Morgan Stanley | 2,265,443 | 1.01% | $18.96M | −168,936 | 0.00% |
| Ranger Investment Management, L.P. | 2,115,417 | 0.94% | $17.71M | −168,393 | 1.12% |
| Charles Schwab Investment Management Inc | 2,092,594 | 0.93% | $17.52M | −3,178 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 323 | 206M | 91.8% | 52 / 90 | 148 / 83 | 45M | 52M |
| Q1 2026 | 357 | 212M | 94.6% | 70 / 136 | 109 / 61 | 71M | 58M |
| Q4 2025 | 356 | 220M | 98.4% | 59 / 140 | 119 / 61 | 31M | 30M |
| Q3 2025 | 365 | 220M | 98.1% | 65 / 97 | 161 / 64 | 39M | 31M |
| Q2 2025 | 368 | 212M | 94.5% | 79 / 152 | 107 / 55 | 28M | 24M |
| Q1 2025 | 347 | 207M | 92.5% | 68 / 128 | 112 / 37 | 28M | 20M |
| Q4 2024 | 321 | 204M | 91.2% | 76 / 124 | 104 / 57 | 27M | 30M |
| Q3 2024 | 306 | 209M | 93.3% | 94 / 102 | 95 / 39 | 74M | 28M |
| Q2 2024 | 252 | 181M | 81.0% | 59 / 87 | 85 / 18 | 31M | 32M |
| Q1 2024 | 214 | 183M | 81.7% | 51 / 86 | 53 / 19 | 32M | 22M |
| Q4 2023 | 184 | 173M | 77.3% | 21 / 72 | 58 / 25 | 19M | 17M |
| Q3 2023 | 188 | 171M | 76.4% | 25 / 89 | 46 / 15 | 19M | 13M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ADMA | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 13,966,706 | 6.24% | $116.90M | 0.11% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 8,524,390 | 3.81% | $71.35M | 0.08% | Jun 30, 2026 |
| First Trust NYSE Arca Biotechnology Index Fund | 7,823,567 | 3.49% | $65.48M | 2.33% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 7,793,162 | 3.48% | $65.23M | 0.61% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 7,023,200 | 3.14% | $58.78M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 5,991,537 | 2.67% | $50.15M | 0.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,660,292 | 1.19% | $22.27M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,522,472 | 1.13% | $21.11M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,521,484 | 1.13% | $21.33M | 0.06% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 2,131,117 | 0.95% | $17.84M | 0.11% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 2,129,592 | 0.95% | $17.82M | 0.12% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 2,082,705 | 0.93% | $17.43M | 0.21% | Jun 30, 2026 |
| iShares Biotechnology ETF | 1,598,768 | 0.71% | $13.38M | 0.15% | Jun 30, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 1,565,647 | 0.70% | $13.10M | 0.11% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1,448,225 | 0.65% | $12.12M | 0.03% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Adam S. Grossman | President and CEO, Director | 2,699,734 | 1.21% | Mar 17, 2026 |
| Kaitlin M. Kestenberg-Messina | COO and SVP, Compliance | 443,061 | 0.20% | Jul 28, 2026 |
| Terry Kohler | CFO and Treasurer | 143,149 | 0.06% | Jul 17, 2026 |
| Brad L. Tade | CFO and Treasurer | 232,940 | 0.10% | Feb 23, 2026 |
| Jerrold B. Grossman | Director | 543,141 | 0.24% | May 28, 2026 |
| Lawrence P. Guiheen | Director | 186,510 | 0.08% | Mar 17, 2026 |
| Steve Elms | Director | 2,143,750 | 0.96% | Mar 9, 2026 |
| Young Kwon | Director | 263,020 | 0.12% | Feb 11, 2026 |
| Alison Cecily Finger | Director | 45,619 | 0.02% | Feb 11, 2026 |
| Eduardo Rene Salas | Director | 21,579 | 0.01% | Feb 11, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Jul 24, 2026 | Tax withholding | −3,177 | $8.37 | $26.59K | 443,061 |
| Terry Kohler CFO and Treasurer | Jul 16, 2026 | Award | +85,130 | – | – | 143,149 |
| Jerrold B. Grossman Director | May 27, 2026 | Buy | +6,400 | $7.91 | $50.62K | 520,284 |
| Jerrold B. Grossman Director | May 12, 2026 | Buy | +12,500 | $8.01 | $100.13K | 513,884 |
| Jerrold B. Grossman Director | May 11, 2026 | Buy | +12,500 | $8.01 | $100.13K | 501,384 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Apr 1, 2026 | Tax withholding | −20,362 | $9.11 | $185.50K | 446,238 |
| Lawrence P. Guiheen Director | Mar 17, 2026 | Gift | −30,000 | – | – | 105,520 |
| Lawrence P. Guiheen Director | Mar 17, 2026 | Gift | +30,000 | – | – | 30,000 |
| Adam S. Grossman President and CEO, Director | Mar 16, 2026 | Sale(10b5-1 plan) | −15,000 | $15.16 | $227.40K | 2,118,777 |
| Adam S. Grossman President and CEO, Director | Mar 16, 2026 | Sale(10b5-1 plan) | −6,000 | $15.16 | $90.96K | 2,112,777 |
| Adam S. Grossman President and CEO, Director | Mar 16, 2026 | Option exercise | +15,000 | $5.40 | $81.00K | 2,133,777 |
| Lawrence P. Guiheen Director | Mar 13, 2026 | Option exercise | +30,000 | $3.66 | $109.80K | 135,520 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 9, 2026 | Option exercise | +1,525 | $2.35 | $3.58K | 474,521 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 9, 2026 | Option exercise | +2,175 | $1.55 | $3.37K | 476,696 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 9, 2026 | Sale | −10,096 | $15.63 | $157.80K | 466,600 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 9, 2026 | Option exercise | +2,646 | $2.83 | $7.49K | 472,996 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 9, 2026 | Option exercise | +1,250 | $4.31 | $5.39K | 470,350 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 9, 2026 | Option exercise | +2,500 | $5.00 | $12.50K | 469,100 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 9, 2026 | Other | −91,266 | – | – | 466,600 |
| Adam S. Grossman President and CEO, Director | Mar 7, 2026 | Tax withholding | −29,513 | $15.39 | $454.21K | 2,118,777 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 7, 2026 | Tax withholding | −4,235 | $15.39 | $65.18K | 557,866 |
| Adam S. Grossman President and CEO, Director | Mar 6, 2026 | Tax withholding | −56,438 | $15.39 | $868.58K | 2,148,290 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Mar 6, 2026 | Tax withholding | −10,059 | $15.39 | $154.81K | 562,101 |
| Steve Elms Director | Mar 6, 2026 | Buy | +7,000 | $15.39 | $107.73K | 2,045,730 |
| Steve Elms Director | Mar 5, 2026 | Buy | +7,000 | $15.67 | $109.69K | 2,038,730 |
| Adam S. Grossman President and CEO, Director | Feb 26, 2026 | Tax withholding | −54,858 | $15.18 | $832.74K | 2,204,728 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Feb 19, 2026 | Tax withholding | −8,161 | $16.32 | $133.19K | 572,160 |
| Adam S. Grossman President and CEO, Director | Feb 19, 2026 | Tax withholding | −24,793 | $16.32 | $404.62K | 2,259,586 |
| Brad L. Tade CFO and Treasurer | Feb 19, 2026 | Tax withholding | −6,479 | $16.32 | $105.74K | 232,940 |
| Adam S. Grossman President and CEO, Director | Feb 17, 2026 | Option exercise | +15,000 | $5.40 | $81.00K | 2,305,379 |
| Adam S. Grossman President and CEO, Director | Feb 17, 2026 | Sale(10b5-1 plan) | −15,000 | $16.08 | $241.20K | 2,290,379 |
| Adam S. Grossman President and CEO, Director | Feb 17, 2026 | Sale(10b5-1 plan) | −6,000 | $16.08 | $96.48K | 2,284,379 |
| Eduardo Rene Salas Director | Feb 9, 2026 | Award | +10,690 | – | – | 21,579 |
| Alison Cecily Finger Director | Feb 9, 2026 | Award | +10,690 | – | – | 45,619 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Feb 9, 2026 | Award | +91,631 | – | – | 580,321 |
| Jerrold B. Grossman Director | Feb 9, 2026 | Award | +10,690 | – | – | 488,884 |
| Adam S. Grossman President and CEO, Director | Feb 9, 2026 | Award | +282,529 | – | – | 2,290,379 |
| Steve Elms Director | Feb 9, 2026 | Award | +10,690 | – | – | 98,020 |
| Young Kwon Director | Feb 9, 2026 | Award | +10,690 | – | – | 263,020 |
| Lawrence P. Guiheen Director | Feb 9, 2026 | Award | +10,690 | – | – | 105,520 |
| Adam S. Grossman President and CEO, Director | Dec 15, 2025 | Sale(10b5-1 plan) | −15,000 | $19.79 | $296.85K | 2,013,850 |
| Adam S. Grossman President and CEO, Director | Dec 15, 2025 | Option exercise | +15,000 | $5.40 | $81.00K | 2,028,850 |
| Adam S. Grossman President and CEO, Director | Dec 15, 2025 | Sale(10b5-1 plan) | −6,000 | $19.79 | $118.74K | 2,007,850 |
| Adam S. Grossman President and CEO, Director | Nov 19, 2025 | Sale(10b5-1 plan) | −15,000 | $16.00 | $240.00K | 2,019,850 |
| Adam S. Grossman President and CEO, Director | Nov 19, 2025 | Option exercise | +15,000 | $5.40 | $81.00K | 2,034,850 |
| Adam S. Grossman President and CEO, Director | Nov 19, 2025 | Sale(10b5-1 plan) | −6,000 | $16.00 | $96.00K | 2,013,850 |
| Adam S. Grossman President and CEO, Director | Oct 24, 2025 | Option exercise | +15,000 | $5.40 | $81.00K | 2,040,850 |
| Adam S. Grossman President and CEO, Director | Oct 24, 2025 | Sale(10b5-1 plan) | −6,000 | $16.00 | $96.00K | 2,019,850 |
| Adam S. Grossman President and CEO, Director | Oct 24, 2025 | Sale(10b5-1 plan) | −15,000 | $16.00 | $240.00K | 2,025,850 |
| Adam S. Grossman President and CEO, Director | Sep 15, 2025 | Sale(10b5-1 plan) | −6,000 | $16.13 | $96.78K | 2,025,850 |
| Adam S. Grossman President and CEO, Director | Sep 15, 2025 | Sale(10b5-1 plan) | −15,000 | $16.13 | $241.95K | 2,031,850 |
| Adam S. Grossman President and CEO, Director | Sep 15, 2025 | Option exercise | +15,000 | $5.40 | $81.00K | 2,046,850 |
| Adam S. Grossman President and CEO, Director | Aug 15, 2025 | Sale(10b5-1 plan) | −6,000 | $16.88 | $101.28K | 2,031,850 |
| Adam S. Grossman President and CEO, Director | Aug 15, 2025 | Sale(10b5-1 plan) | −15,000 | $16.88 | $253.20K | 2,037,850 |
| Adam S. Grossman President and CEO, Director | Aug 15, 2025 | Option exercise | +15,000 | $5.40 | $81.00K | 2,052,850 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Jul 30, 2025 | Tax withholding | −1,208 | $18.59 | $22.46K | 488,690 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Jul 30, 2025 | Option exercise | +2,500 | $8.98 | $22.45K | 489,898 |
| Brad L. Tade CFO and Treasurer | Jul 24, 2025 | Tax withholding | −7,123 | $17.31 | $123.30K | 239,419 |
| Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | Jul 24, 2025 | Tax withholding | −3,027 | $17.31 | $52.40K | 487,398 |
| Adam S. Grossman President and CEO, Director | Jul 15, 2025 | Option exercise | +15,000 | $5.40 | $81.00K | 2,058,850 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Brad L. Tade Former Officer | Mar 10, 2026 | 50,026 | $790.91K | Mar 10, 2026 | Restricted Stock Units vesting - granted June 26, 2023 |
| Kaitlin M. Kestenberg-Messina Officer | Mar 9, 2026 | 10,096 | $155.38K | Mar 9, 2026 | Stock Option Exercise - Options Granted February 14, 2017 |
| Adam S. Grossman Director, Officer | Feb 17, 2026 | 209,000 | $3.36M | Feb 17, 2026 | Stock Option Exercise - Options Granted February 26, 2024 |
| Adam S. Grossman Director and Officer | Oct 24, 2025 | 63,000 | $960.75K | Oct 24, 2025 | Stock Option Exercise - Options |
| Adam S. Grossman Director and Officer | Jul 15, 2025 | 63,000 | $1.18M | Jul 15, 2025 | Stock Option Exercise - Options Granted February 26, 2024 |
| Steve Elms Director | Jun 12, 2025 | 425,621 | $9.31M | Jun 12, 2025 | Restricted Stock Units vested |
| Jerrold B. Grossman Director | Jun 9, 2025 | 10,000 | $206.10K | Jun 9, 2025 | Stock Option Exercise - Options Granted February 14, 2017 |
| P. Guiheen Rev Tr DTD 09/20/19 Lawrence Director | Jun 4, 2025 | 20,000 | $415.00K | Jun 4, 2025 | OPTIONS EXERCISED |
| Lawrence P. Guiheen Director | May 21, 2025 | 29,000 | $572.76K | May 21, 2025 | Stock Option Exercise - Options granted 1/28/2016 |
| Adam S. Grossman Director and Officer | Mar 19, 2025 | 84,000 | $1.57M | Mar 19, 2025 | Restricted Stock Units Vesting |
| Adam S. Grossman Director and Officer | Nov 22, 2024 | 48,967 | $1.04M | Nov 22, 2024 | Restricted Stock Unit Vest |
| Brad L. Tade Officer | Nov 22, 2024 | 15,000 | $319.50K | Nov 22, 2024 | Restricted Stock Unit Vest |
| Lawrence P. Guiheen Director | Sep 9, 2024 | 9,000 | $146.34K | Sep 9, 2024 | Stock Options |
| Kaitlin M. Kestenberg-Messina Officer | Aug 30, 2024 | 24,150 | $415.86K | Aug 30, 2024 | Stock Options |
| Jerrold B. Grossman Director | Aug 29, 2024 | 136,861 | $2.36M | Aug 29, 2024 | Stock Options |